These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10395375)

  • 1. Ligand-dependent regulation of plasmid-based transgene expression in vivo.
    Abruzzese RV; Godin D; Burcin M; Mehta V; French M; Li Y; O'Malley BW; Nordstrom JL
    Hum Gene Ther; 1999 Jun; 10(9):1499-507. PubMed ID: 10395375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system.
    Abruzzese RV; Godin D; Mehta V; Perrard JL; French M; Nelson W; Howell G; Coleman M; O'Malley BW; Nordstrom JL
    Mol Ther; 2000 Sep; 2(3):276-87. PubMed ID: 10985958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor.
    Roscilli G; Rinaudo CD; Cimino M; Sporeno E; Lamartina S; Ciliberto G; Toniatti C
    Mol Ther; 2002 Nov; 6(5):653-63. PubMed ID: 12409264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
    Yu YA; Szalay AA
    Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAXI/UAS: A molecular switch to control expression of genes in vivo.
    Delort JP; Capecchi MR
    Hum Gene Ther; 1996 May; 7(7):809-20. PubMed ID: 8860833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A versatile framework for the design of ligand-dependent, transgene-specific transcription factors.
    Xu L; Zerby D; Huang Y; Ji H; Nyanguile OF; de los Angeles JE; Kadan MJ
    Mol Ther; 2001 Feb; 3(2):262-73. PubMed ID: 11237684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-regulatable erythropoietin production by plasmid injection and in vivo electroporation.
    Terada Y; Tanaka H; Okado T; Shimamura H; Inoshita S; Kuwahara M; Akiba T; Sasaki S
    Kidney Int; 2002 Dec; 62(6):1966-76. PubMed ID: 12427121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
    Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B
    Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
    Riu E; Grimm D; Huang Z; Kay MA
    Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between transgen expression and plasmid DNA loss in mouse liver.
    Togashi R; Harashima H; Kamiya H
    J Gene Med; 2013; 15(6-7):242-8. PubMed ID: 23765503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
    Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
    Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated expression of the interferon-beta gene in mice.
    Harkins RN; Szymanski P; Petry H; Brooks A; Qian HS; Schaefer C; Kretschmer PJ; Orme A; Wang P; Rubanyi GM; Hermiston TW
    Gene Ther; 2008 Jan; 15(1):1-11. PubMed ID: 17637794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating gene expression using self-inactivating lentiviral vectors containing the mifepristone-inducible system.
    Sirin O; Park F
    Gene; 2003 Dec; 323():67-77. PubMed ID: 14659880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an improved inducer-regulator protein complex in the pBRES-regulated expression system.
    Levitsky K; Szymanski P; Jin F; Meurer-Ogden JA; Harkins RN
    Hum Gene Ther; 2008 Nov; 19(11):1273-82. PubMed ID: 19000019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly-L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation.
    Nicol F; Wong M; MacLaughlin FC; Perrard J; Wilson E; Nordstrom JL; Smith LC
    Gene Ther; 2002 Oct; 9(20):1351-8. PubMed ID: 12365000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conditional tissue-specific transgene expression system using inducible GAL4.
    Osterwalder T; Yoon KS; White BH; Keshishian H
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12596-601. PubMed ID: 11675495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
    Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
    Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiprogestin-dependent GeneSwitch system for regulated gene therapy.
    Nordstrom JL
    Steroids; 2003 Nov; 68(10-13):1085-94. PubMed ID: 14668002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.